BAG Freiberg-Richter, Jacobasch, Illmer, Wolf

Dresden 01307

0 studies enrolling now · 2 studies all time

What they study most

Lymphocytic Leukemia, Chronic, Relapsed or Refractory Follicular Lymphoma

Studies at this site

• A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma — Running, not enrolling
• Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia — Completed